Leqvio Market Report 2026
Download Free Sample Buy Now
Leqvio Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Leqvio Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Leqvio Market Overview

• The Leqvio market growth in the historic period has been driven by increasing prevalence of hyperlipidemia, advancements in rna interference technology

• Market expansion is supported by increasing adoption of novel rna therapeutics, rising focus on cardiovascular risk reduction

• Growth Driver: Growing Geriatric Population Drives The Leqvio Market Expansion

• Market Trend: Advancements In Long-Acting Injectable Therapies For High Cholesterol And Cardiovascular Risk Management

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Leqvio Market?

Leqvio is an siRNA-based therapy that reduces low-density lipoprotein (LDL) cholesterol by silencing the mRNA responsible for PCSK9 production in the liver. It improves the liver's ability to clear LDL-C from the bloodstream, lowering the risk of heart attacks, strokes, and other cardiovascular events in high-risk patients.

The main types of leqvio formulation are injectable formulation (subcutaneous) and pre-filled syringes or auto-injectors. Leqvio's subcutaneous injectable formulation is administered in a healthcare setting, delivering a controlled, long-term dosage typically every six months after an initial dose. It is applicable for various indications, including treatment of hyperlipidemia, management of atherosclerotic cardiovascular disease (ASCVD), and treatment of familial hypercholesterolemia for several patient demographics, such as adult patients, geriatric patients, and patients with comorbid conditions. It is distributed by various distribution channels, including direct sales, wholesalers and distributors, retail pharmacies, and online pharmacies, and used by several end users, such as hospitals, cardiovascular clinics, specialty pharmacies, and home healthcare providers.

Leqvio Market Global Report 2026 Market Report bar graph

What Is The Leqvio Market Size and Share 2026?

The growth in the historic period can be attributed to increasing prevalence of hyperlipidemia, advancements in rna interference technology, expansion of cardiovascular specialty clinics, growing awareness of ldl cholesterol management, improved injectable drug delivery systems.

What Is The Leqvio Market Growth Forecast?

The growth in the forecast period can be attributed to increasing adoption of novel rna therapeutics, rising focus on cardiovascular risk reduction, expansion of long-interval dosing therapies, growing investments in cardiometabolic research, increasing demand for durable lipid-lowering solutions. Major trends in the forecast period include increasing adoption of sirna-based lipid-lowering therapies, rising demand for long-acting cardiovascular treatments, growing focus on preventive cardiology solutions, expansion of advanced rna manufacturing technologies, enhanced emphasis on patient adherence optimization.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Leqvio Market Segmentation

1) By Formulation: Injectable Formulation (Subcutaneous), Pre-Filled Syringes Or Auto-Injectors

2) By Indication: Treatment Of Hyperlipidemia, Management Of Atherosclerotic Cardiovascular Disease (ASCVD), Treatment Of Familial Hypercholesterolemia

3) By Patient Demographics: Adult Patients, Geriatric Patients, Patients with Comorbid Conditions

4) By Distribution Channel: Direct Sales, Wholesalers and Distributors, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Cardiovascular Clinics, Specialty Pharmacies, Home Healthcare Providers

What Is The Driver Of The Leqvio Market?

The growing geriatric population is expected to boost the growth of the leqvio demand going forward. The geriatric population consists of individuals, usually aged 65 and above. Advancements in healthcare and medical technology have significantly boosted life expectancy, contributing to the growth of the geriatric population. Leqvio lowers LDL cholesterol, easing medication management for older adults. Its long-lasting effect reduces cardiovascular risks, enhancing health outcomes in the geriatric population. For instance, in January 2024, according to the Population Reference Bureau, a Kenya-based nonprofit organization, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase. This age group's share of the overall population is also projected to rise from 17% to 23% during the same period. Therefore, the growing geriatric population is driving the growth of the leqvio industry.

Key Players In The Global Leqvio Market

Major companies operating in the leqvio market are Novartis AG

Global Leqvio Market Trends and Insights

Major companies are operating in the leqvio market, focusing on developing advanced injectable prescription medicine such as Label Expansion to enhance therapeutic accessibility and early intervention. Label Expansion refers to the regulatory approval granted by authorities, such as the FDA, that allows an already authorized drug to be used for additional indications, patient groups, or clinical settings beyond its original approved use. For instance, in July 2023, Novartis AG, a Switzerland-based pharmaceutical company, received US Food and Drug Administration (FDA) approval for a label update for Leqvio (inclisiran), allowing its use at an earlier stage for patients with elevated LDL-C and an increased risk of heart disease, in addition to diet and statin therapy. With two doses per year after two initial doses, it provides up to a 52% LDL-C reduction and is proven effective for patients unable to reach their LDL-C target despite statin therapy. The label update highlights robust safety and efficacy data reinforced by the VictORION clinical trial program.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Leqvio Market?

In November 2019, Novartis AG, a Switzerland-based pharmaceutical company, acquired The Medicines Company for US$ 9.7 billion. With this acquisition, Novartis gained global rights to inclisiran (later branded Leqvio) and significantly strengthened its cardiovascular-lipid lowering franchise. The Medicines Company was a US-based biopharma firm focused on siRNA-based cholesterol-lowering therapies under license from Alnylam.

Regional Insights

North America was the largest region in the leqvio market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Leqvio Market?

The leqvio market consists of sales of multi-dose vials and ready-to-use liquid vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Leqvio Market Report 2026?

The leqvio market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the leqvio industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Leqvio Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Formulation, Indication, Patient Demographics, Distribution Channel, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Novartis AG
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Leqvio Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Leqvio Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Leqvio Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Leqvio Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Sustainability, Climate Tech & Circular Economy

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Increasing Adoption Of Sirna-Based Lipid-Lowering Therapies

4.2.2 Rising Demand For Long-Acting Cardiovascular Treatments

4.2.3 Growing Focus On Preventive Cardiology Solutions

4.2.4 Expansion Of Advanced Rna Manufacturing Technologies

4.2.5 Enhanced Emphasis On Patient Adherence Optimization

5. Leqvio Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Cardiovascular Clinics

5.3 Specialty Pharmacies

5.4 Home Healthcare Providers

5.5 Preventive Care Centers

6. Leqvio Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Leqvio Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Leqvio PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Leqvio Market Size, Comparisons And Growth Rate Analysis

7.3. Global Leqvio Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Leqvio Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Leqvio Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Leqvio Market Segmentation

9.1. Global Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable Formulation (Subcutaneous), Pre-Filled Syringes Or Auto-Injectors

9.2. Global Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Treatment Of Hyperlipidemia, Management Of Atherosclerotic Cardiovascular Disease (ASCVD), Treatment Of Familial Hypercholesterolemia

9.3. Global Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult Patients, Geriatric Patients, Patients With Comorbid Conditions

9.4. Global Leqvio Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

9.5. Global Leqvio Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Cardiovascular Clinics, Specialty Pharmacies, Home Healthcare Providers

10. Leqvio Market Regional And Country Analysis

10.1. Global Leqvio Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Leqvio Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Leqvio Market

11.1. Asia-Pacific Leqvio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Leqvio Market

12.1. China Leqvio Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Leqvio Market

13.1. India Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Leqvio Market

14.1. Japan Leqvio Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Leqvio Market

15.1. Australia Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Leqvio Market

16.1. South Korea Leqvio Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Leqvio Market

17.1. Western Europe Leqvio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Leqvio Market

18.1. UK Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Leqvio Market

19.1. Germany Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Leqvio Market

20.1. France Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Leqvio Market

21.1. Eastern Europe Leqvio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Leqvio Market

22.1. North America Leqvio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Leqvio Market

23.1. USA Leqvio Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Leqvio Market

24.1. Canada Leqvio Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Leqvio Market

25.1. South America Leqvio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Leqvio Market

26.1. Middle East Leqvio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Leqvio Market

27.1. Africa Leqvio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Leqvio Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Leqvio Market Regulatory and Investment Landscape

29. Leqvio Market Competitive Landscape And Company Profiles

29.1. Leqvio Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Leqvio Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Leqvio Market Company Profiles

29.3.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30. Global Leqvio Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Leqvio Market

32. Leqvio Market High Potential Countries, Segments and Strategies

32.1 Leqvio Market In 2030 - Countries Offering Most New Opportunities

32.2 Leqvio Market In 2030 - Segments Offering Most New Opportunities

32.3 Leqvio Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Leqvio Market, Overview Of Key Products - Product Examples
  • Table 2: Global Leqvio Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Leqvio Market, Supply Chain Analysis
  • Table 4: Global Leqvio Market, Major Raw Material Providers
  • Table 5: Global Leqvio Market, Major Resource Providers
  • Table 6: Global Leqvio Market, Major Manufacturers (Suppliers)
  • Table 7: Global Leqvio Market, Major Distributors And Channel Partners
  • Table 8: Global Leqvio Market, Key Technologies & Future Trends
  • Table 9: Global Leqvio Market, Major Trends
  • Table 10: Global Leqvio Market, Major End Users
  • Table 11: Global Leqvio Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Leqvio Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Leqvio Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Leqvio Market - TAM, US$ Billion, 2025
  • Table 15: Global Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Leqvio Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Leqvio Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Leqvio Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Leqvio Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: South Korea, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Western Europe, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Western Europe, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: UK, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: UK, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Germany, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Germany, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: France, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: France, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Eastern Europe, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Eastern Europe, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: North America, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: North America, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: USA, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: USA, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Canada, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Canada, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: South America, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: South America, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Middle East, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Middle East, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Africa, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Africa, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Global Leqvio Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 74: Global Leqvio Market - Company Scoring Matrix
  • Table 75: Novartis AG Financial Performance
  • Table 76: Global Leqvio Market, Competitive Benchmarking (In USD Billions)
  • Table 77: Global Leqvio Market, Competitive Dashboard
  • Table 78: Global Leqvio Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 79: Global, Leqvio Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Table 80: Global, Leqvio Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 81: Global, Leqvio Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

List Of Figures

    Figure 1: Global Leqvio Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Leqvio Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Leqvio Market, Supply Chain Analysis
  • Figure 4: Global Leqvio Market, Major Raw Material Providers
  • Figure 5: Global Leqvio Market, Major Resource Providers
  • Figure 6: Global Leqvio Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Leqvio Market, Major Distributors And Channel Partners
  • Figure 8: Global Leqvio Market, Key Technologies & Future Trends
  • Figure 9: Global Leqvio Market, Major Trends
  • Figure 10: Global Leqvio Market, Major End Users
  • Figure 11: Global Leqvio Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Leqvio Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Leqvio Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Leqvio Market - TAM, US$ Billion, 2025
  • Figure 15: Global Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Leqvio Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Leqvio Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Leqvio Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Leqvio Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: South Korea, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Western Europe, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Western Europe, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: UK, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: UK, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Germany, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Germany, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: France, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: France, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Eastern Europe, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Eastern Europe, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: North America, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: North America, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: USA, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: USA, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Canada, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Canada, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: South America, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: South America, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Middle East, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Middle East, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Leqvio Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Africa, Leqvio Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Africa, Leqvio Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Global Leqvio Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 74: Global Leqvio Market - Company Scoring Matrix
  • Figure 75: Novartis AG Financial Performance
  • Figure 76: Global Leqvio Market, Competitive Benchmarking (In USD Billions)
  • Figure 77: Global Leqvio Market, Competitive Dashboard
  • Figure 78: Global Leqvio Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 79: Global, Leqvio Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Figure 80: Global, Leqvio Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 81: Global, Leqvio Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Inductor Global Market Report 2024 – By Type (Film Type, Multilayered, Wire Wound, Molded), By Inductance (Fixed Inductors, Variable Inductors), By Core Type (Air Core, Ferromagnetic/Ferrite Core, Iron Core), By Applicat...

Vertical Market Software Market Report 2026 - Global Outlook – By Software Type (Banking Software, Education Software, Legal Software, Agriculture Software, Alumni Management Software, Amusement Park Software, Apparel So...

Data Lake Market Report 2026 - Global Outlook – By Type (Solution, Services), By Deployment (On-Premise, Cloud), By Organization Size (Large Enterprises, Small And Medium-Sized Enterprises (SMEs)), By Vertical (Informati...

Premium Finance Market Report 2026 - Global Outlook – By Type (Life Insurance, Non-Life Insurance), By Interest Rate (Fixed Interest Rate, Floating Interest Rate), By Provider (Banks, Non-Banking Financial Company (NBFCs...

Alternative Finance Market Report 2026 - Global Outlook – By Type (Peer-To-Peer Lending, Crowdfunding, Invoice Trading, Other Types), By Business Model (Non-Bank Lending, Alternate Marketplace Lending), By End User (Ente...

Market Research Services Market Report 2026 - Global Outlook – By Type (Marketing Research And Analysis Services, Public Opinion And Election Polling), By Research Methodology (Qualitative Research, Quantitative Research...

Sustainable Finance Market Report 2026 - Global Outlook – By Investment Type (Equity, Fixed Income, Mixed Allocation, Other Investment Types), By Transaction Type (Green Bond, Social Bond, Mixed-Sustainability Bond, Envi...

Trade Finance Market Report 2026 - Global Outlook – By Type (Supply Chain Finance, Structured Trade Finance, Traditional Trade Finance), By Service Provider (Banks, Financial Institutions, Trading Houses, Other Services)...

Frequently Asked Questions

The Leqvio market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Leqvio market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Leqvio market Include, Novartis AG .

Major trend in this market includes: Advancements In Long-Acting Injectable Therapies For High Cholesterol And Cardiovascular Risk Management. For further insights on this market. request a sample here

North America was the largest region in the leqvio market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leqvio market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us